Model Number ESS205 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Myalgia (2238)
|
Event Date 01/01/2009 |
Event Type
Injury
|
Event Description
|
The below report was received by health authority ansm (reference number: (b)(4)) on 01-mar-2023.This spontaneous case was originally reported by a consumer and describes the occurrence of musculoskeletal pain ("joint and muscle pain") in an adult female patient who had essure (ess205) inserted (lot no.621805, 620727) for female sterilisation.Additional non-serious events are detailed below.There was no information on the patient's medical history or concurrent conditions.On (b)(6) 2007, the patient had essure (ess205) inserted.In 2009 she experienced musculoskeletal pain (seriousness criterion medically important), tendonitis ("tendinitis of the shoulders and elbows"), rotator cuff syndrome ("tendinitis of the shoulders and elbows"), neck pain ("neck pain"), sleep disorder ("sleep disorder"), asthenia ("asthenia"), eczema ("auditory canal itching"), cough ("recurrent dry cough"), aphasia ("memory disorder with difficulty finding words"), constipation ("constipation"), pain in extremity ("pain in the hands") and meniscus injury ("meniscus micro-fracture without any impact").An unknown time later she experienced burnout syndrome ("burn out").No causality assessment was received for essure (ess205) with regard to tendonitis, rotator cuff syndrome, neck pain, musculoskeletal pain, sleep disorder, asthenia, eczema, cough, aphasia, constipation, pain in extremity, meniscus injury or burnout syndrome.Diagnostic results (normal ranges are provided in parenthesis if available): body weight was reported to be 69 kg.A technical investigation will be conducted, including a batch review, and a review of complaint records and other relevant data; should any new and reportable information become available from our investigation, this will be provided in a supplementary report.
|
|
Manufacturer Narrative
|
The below report was received by health authority ansm (reference number: (b)(4)) on 01-mar-2023.The most recent information was received on 09-mar-2023.This spontaneous case was originally reported by a consumer and describes the occurrence of musculoskeletal pain ("joint and muscle pain") in an adult female patient who had essure (ess205) inserted (lot no.620727, 621805) for female sterilisation.Additional non-serious events are detailed below.There was no information on the patient's medical history or concurrent conditions.On (b)(6) 2007, the patient had essure (ess205) inserted.In 2009 she experienced musculoskeletal pain (seriousness criterion medically important), tendonitis ("tendinitis of the shoulders and elbows"), rotator cuff syndrome ("tendinitis of the shoulders and elbows"), neck pain ("neck pain"), sleep disorder ("sleep disorder"), asthenia ("asthenia"), eczema ("auditory canal itching"), cough ("recurrent dry cough"), aphasia ("memory disorder with difficulty finding words"), constipation ("constipation"), pain in extremity ("pain in the hands") and meniscus injury ("meniscus micro-fracture without any impact").An unknown time later she experienced burnout syndrome ("burn out").No causality assessment was received for essure (ess205) with regard to tendonitis, rotator cuff syndrome, neck pain, musculoskeletal pain, sleep disorder, asthenia, eczema, cough, aphasia, constipation, pain in extremity, meniscus injury or burnout syndrome.Diagnostic results (normal ranges are provided in parenthesis if available): body weight was reported to be 69 kg.Lot number: 620727, manufacture date: 2006-07, and expiration date: 2008-04.Lot number: 621805, manufacture date: 2006-12, and expiration date: 2008-11.Quality-safety evaluation of ptc: for essure (ess205): no defect could be confirmed by the manufacturer.All component batches used for manufacturing of this product batch fulfilled the set specifications.Batch documentation did not reveal any deviations during the manufacturing process that could have caused the described complaint reason.Trend analyses of complaints are reviewed regularly, no signal was observed with regard to the reported complaint reason.The risk management file was reviewed and an update was not deemed required.A technical investigation of the complaint sample could not be conducted, as no sample was available.The most recent follow-up information incorporated above includes data received on: 09-mar-2023: quality safety evaluation of ptc.A technical investigation was conducted, including a batch review, and a review of complaint records and other relevant data; should any new and reportable information become available from our investigation, this will be provided in a supplementary report.
|
|
Search Alerts/Recalls
|
|